Organization
Amgen, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Amgen, Inc.
... Amgen (NASDAQ:AMGN) announced that the ENBREL Mini(TM) with AutoTouch(TM) is now available in ...
... reimbursement plans will further accelerate growth. Key players include Novartis International AG, Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc, F. Hoffmann-La Roche ...
... target FDA action date of April 30, 2018.Kyprolis®, developed and marketed by Amgen (worldwide, ex-Japan) and Ono Pharmaceuticals (Japan), for the treatment of multiple myeloma, ...
... Amgen (NASDAQ:AMGN) today announced five new subgroup analyses from the Repatha® (evolocumab) cardiovascular ...
... Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use ...
... Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced that the Committee for Medicinal ...
... Amgen (NASDAQ: AMGN) today announced new analyses will be presented from the Repatha® (evolocumab) ...
... Union Pacific Corporation (NYSE:UNP), HCA Holdings, Inc. (NYSE:HCA), PulteGroup, Inc. (NYSE:PHM), Amgen Inc. (NASDAQ:AMGN), Eli Lilly and Company (NYSE:LLY), and The AES Corporation (NYSE:AES) including ...
... Recombinant DNA (rDNA) Technology market are F. Hoffmann-La Roche Ltd, Monsanto Company, Amgen Inc, Biocon, Biogen, Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Horizon Discovery ...
... Amgen (NASDAQ:AMGN) and Novartis today announced an expanded collaboration with the Banner Alzheimer's ...
... Amgen (NASDAQ:AMGN) today announced that Amgen and Kirin Holdings (Kirin) have agreed that ...
... The biotech had 410 employees in February. ( Endpoints News ) 3. Amgen ended its R&D efforts for an experimental cholesterol drug, which was part ...
... & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, AbbVie Inc., Amgen Inc., Lilly, Bristol-Myers Squibb, Novo Nordisk, Merck KGaA, Allergan, Plc, Boehringer Ingelheim ...
... AEG, owner and presenter of the Amgen Tour of California , welcomes 11 Host Cities across the state for ...
... Astellas First Patient Recently Dosed in Japan in GALACTIC-HF Under Collaboration with Amgen SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ...
... Amgen has scrapped development of the CETP inhibitor it acquired in its $1.55 ...
... Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2017. Key ...
... New research brings that hope a notch closer. Scientists from biotechnology company Amgen Inc. report they have identified and improved upon a naturally occurring protein ...
... Amgen (NASDAQ: AMGN) today announced that its Board of Directors declared a $1.15 per ...
... Amgen (NASDAQ:AMGN) today announced the launch ofAt Home with Joan, a campaign led ...
... THOUSAND OAKS - Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results ...
... Amgen (NASDAQ: AMGN) today announced top-line results of the Phase 3 A.R.R.O.W. trial, which ...
... Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results ...
... of leading companies in the antibody drug industry, such as AbbVie Inc., Amgen Inc., Biogen Inc., Johnson & Johnson Inc., Merck KGaA, Novartis AG, F. ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤